| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |